Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Statements of Stockholders' Equity

v3.26.3
Consolidated Condensed Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Public Stock Offering
Escrowed Shares
Opening Balance Adjustment
 [1]
Common Stock and Capital in Excess of Par Value
Common Stock and Capital in Excess of Par Value
Public Stock Offering
Common Stock and Capital in Excess of Par Value
Escrowed Shares
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Opening Balance Adjustment
 [1]
Noncontrolling Interest
Number of shares, beginning balance (in shares) at Dec. 28, 2024         4,330            
Stockholders' equity, beginning balance at Dec. 28, 2024 $ 105,032     $ 49 $ 50,949     $ (711) $ 49,032 $ 49 $ 5,762
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 359               324   35
Other comprehensive income (loss) 730             730      
Net proceeds from stock issuances and warrants (in shares) [2]         362            
Net proceeds from stock issuances and warrants [2] 3,758       $ 3,758            
Partner contributions and issuance/sale of subsidiary shares 4,574       $ 58           4,516
Partner distributions declared (159)                   (159)
Employee equity incentive plans and other (in shares)         88            
Employee equity incentive plans and other 777       $ 777            
Share-based compensation 1,896       $ 1,696           200
Restricted stock unit withholdings (in shares)         (14)            
Restricted stock unit withholdings (286)       $ (483)       197    
Number of shares, ending balance (in shares) at Sep. 27, 2025         4,766            
Stockholders' equity, ending balance at Sep. 27, 2025 116,730       $ 56,755     19 49,602   10,354
Number of shares, beginning balance (in shares) at Jun. 28, 2025         4,377            
Stockholders' equity, beginning balance at Jun. 28, 2025 105,751       $ 52,334     65 45,484   7,868
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 4,270               4,063   207
Other comprehensive income (loss) (46)             (46)      
Net proceeds from stock issuances and warrants (in shares) [2]         362            
Net proceeds from stock issuances and warrants [2] 3,758       $ 3,758            
Partner contributions and issuance/sale of subsidiary shares 2,336       $ 60           2,276
Partner distributions declared (68)                   (68)
Employee equity incentive plans and other (in shares)         32            
Employee equity incentive plans and other 286       $ 286            
Share-based compensation 548       $ 477           71
Restricted stock unit withholdings (in shares)         (5)            
Restricted stock unit withholdings (105)       $ (160)       55    
Number of shares, ending balance (in shares) at Sep. 27, 2025         4,766            
Stockholders' equity, ending balance at Sep. 27, 2025 $ 116,730       $ 56,755     19 49,602   10,354
Number of shares, beginning balance (in shares) at Dec. 27, 2025 4,994       4,994            
Stockholders' equity, beginning balance at Dec. 27, 2025 $ 126,360       $ 65,185     113 48,983   12,079
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (11,609)               (11,441)   (168)
Other comprehensive income (loss) (345)             (345)      
Net proceeds attributed to common stock / Escrowed Shares issued (in shares)           242 24        
Net proceeds attributed to common stock/ Escrowed Shares issued   $ 22,617 $ 2,024     $ 22,617 $ 2,024        
Partner contributions and issuance/sale of subsidiary shares 5,059                   5,059
Partner distributions declared and repurchase of subsidiary shares (14,147)       $ (13,545)           (602)
Partner distributions declared (427)                    
Employee equity incentive plans and other (in shares)         62            
Employee equity incentive plans and other 736       $ 736            
Share-based compensation 1,768       $ 1,494           274
Restricted stock unit withholdings (in shares)         (12)            
Restricted stock unit withholdings $ (907)       $ (334)       (573)    
Number of shares, ending balance (in shares) at Sep. 26, 2026 5,310       5,310            
Stockholders' equity, ending balance at Sep. 26, 2026 $ 131,556       $ 78,177     (232) 36,969   16,642
Number of shares, beginning balance (in shares) at Jun. 27, 2026         5,043            
Stockholders' equity, beginning balance at Jun. 27, 2026 103,143       $ 53,780     (80) 33,842   15,601
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 3,520               3,320   200
Other comprehensive income (loss) (152)             (152)      
Net proceeds attributed to common stock / Escrowed Shares issued (in shares)           242 11        
Net proceeds attributed to common stock/ Escrowed Shares issued   $ 22,617 $ 1,075     $ 22,617 $ 1,075        
Partner contributions and issuance/sale of subsidiary shares 950                   950
Partner distributions declared and repurchase of subsidiary shares (212)                   (212)
Employee equity incentive plans and other (in shares)         17            
Employee equity incentive plans and other 309       $ 309            
Share-based compensation 596       $ 493           103
Restricted stock unit withholdings (in shares)         (3)            
Restricted stock unit withholdings $ (290)       $ (97)       (193)    
Number of shares, ending balance (in shares) at Sep. 26, 2026 5,310       5,310            
Stockholders' equity, ending balance at Sep. 26, 2026 $ 131,556       $ 78,177     $ (232) $ 36,969   $ 16,642
[1] We made a cumulative-effect adjustment to the opening balance of retained earnings upon adopting ASU 2023-08 in 2025.
[2] Includes $110 million of allocated proceeds to warrants from the Warrant and Common Stock Agreement with the U.S. government.
See accompanying notes.